세계의 혈소판 응집 기기 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2032년)

The global demand for Platelet Aggregation Devices Market is presumed to reach the market size of nearly USD 1331.01 Million by 2032 from USD 807.49 Million in 2023 with a CAGR of 5.71% under the study period 2024 - 2032.

Platelet aggregation devices are medical instruments used to assess the ability of platelets in the blood to clot. They measure the aggregation response to various stimuli, help diagnose bleeding disorders, monitor antiplatelet therapy, and assess patients' overall hemostatic function.

MARKET DYNAMICS

The platelet aggregation devices market is witnessing substantial growth, primarily driven by advancements in diagnostic technologies and an increasing prevalence of cardiovascular diseases. Platelet aggregation devices are critical in assessing platelet function and evaluating the risk of thrombotic events. As cardiovascular diseases are a major cause of mortality and morbidity globally, the demand for accurate and precise diagnostic tools is on the rise. Moreover, a growing aging population and lifestyle factors contributing to cardiovascular risk have intensified the need for early detection and management. The continuous research and development efforts to enhance the precision and usability of platelet aggregation devices, coupled with a surge in awareness about preventive healthcare, contribute significantly to the expanding market. However, certain factors, such as the complexity of platelet aggregation testing procedures and the limited awareness among healthcare professionals, may restrain market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of platelet aggregation devices. The growth and trends of platelet aggregation devices industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the platelet aggregation devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

• Systems And Instruments
• Consumables And Accessories

By Application

• Clinical Applications
• Outsourced

By End-Use

• Hospital
• Diagnostic Centers
• Research And Academic Institutes
• Platelet Aggregation Devices

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Platelet Aggregation Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

• GLOBAL PLATELET AGGREGATION DEVICES MARKET SHARE BY REGION (REPRESENTATIVE GRAPH)
• Global Platelet Aggregation Devices Market Share

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Platelet Aggregation Devices market include AggreDyne, Inc.; Bio/Data Corporation; Chrono-Log Corporation; F. Hoffmann-La Roche Ltd.; Haemonetics Corporation; Siemens Healthcare GmbH; Werfen; Sysmex Corporation; Sienco, Inc.; Drucker Diagnostics. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . PLATELET AGGREGATION DEVICES - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product Type
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End-Use
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL PLATELET AGGREGATION DEVICES MARKET ANALYSIS BY PRODUCT TYPE

• 5.1 Overview by Product Type
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Product Type
• 5.4 Systems And Instruments Historic and Forecast Sales by Regions
• 5.5 Consumables And Accessories Historic and Forecast Sales by Regions

6 . GLOBAL PLATELET AGGREGATION DEVICES MARKET ANALYSIS BY APPLICATION

• 6.1 Overview by Application
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Application
• 6.4 Clinical Applications Historic and Forecast Sales by Regions
• 6.5 Outsourced Historic and Forecast Sales by Regions

7 . GLOBAL PLATELET AGGREGATION DEVICES MARKET ANALYSIS BY END-USE

• 7.1 Overview by End-Use
• 7.2 Historical and Forecast Data
• 7.3 Analysis by End-Use
• 7.4 Hospital Historic and Forecast Sales by Regions
• 7.5 Diagnostic Centers Historic and Forecast Sales by Regions
• 7.6 Research And Academic Institutes Historic and Forecast Sales by Regions
• 7.7 Platelet Aggregation Devices Historic and Forecast Sales by Regions

8 . GLOBAL PLATELET AGGREGATION DEVICES MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. South East Asia Sales Analysis
  • 8.5.10. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE PLATELET AGGREGATION DEVICES COMPANIES

• 9.1. Platelet Aggregation Devices Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF PLATELET AGGREGATION DEVICES INDUSTRY

• 10.1. Company Share Analysis
• 10.2. Market Concentration Rate
• 10.3. AggreDyne Inc.
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. Bio/Data Corporation
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Chrono-Log Corporation
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. F. Hoffmann-La
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. Roche Ltd.
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. Haemonetics Corporation
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. Siemens Healthcare GmbH
  • 10.9.1. Company Overview
  • 10.9.2. Company Revenue
  • 10.9.3. Products
  • 10.9.4. Recent Developments
• 10.10. Werfen
  • 10.10.1. Company Overview
  • 10.10.2. Company Revenue
  • 10.10.3. Products
  • 10.10.4. Recent Developments
• 10.11. Sysmex Corporation
  • 10.11.1. Company Overview
  • 10.11.2. Company Revenue
  • 10.11.3. Products
  • 10.11.4. Recent Developments
• 10.12. Sienco Inc.
  • 10.12.1. Company Overview
  • 10.12.2. Company Revenue
  • 10.12.3. Products
  • 10.12.4. Recent Developments
• 10.13. Drucker Diagnostics
  • 10.13.1. Company Overview
  • 10.13.2. Company Revenue
  • 10.13.3. Products
  • 10.13.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies